Is This Drug to Blame for Your Soaring Medicare Premium? – Chris Kissell

LightField Studios / Shutterstock.com

Medicare premiums will soar in 2021 — and at least one federal government official says a new drug used to treat Alzheimer’s disease is partially to blame. As we have reported, the Medicare Part B standard premium will jump by $21.60 in 2022, while the Part B annual deductible will rise by $30. These hikes have surprised and outraged many Medicare recipients. However, an unnamed official with the…

Read More